D.R. Horton
DHI
Taylor Morrison Home
TMHC
Lennar Corp
LEN
Toll Brothers
TOL
Apple
AAPL
US Stock MarketDetailed Quotes
MRNA Moderna
- 34.029
- -0.681-1.96%
Trading Mar 18 09:50 ET
13.13BMarket Cap-3.67P/E (TTM)
34.539High33.592Low927.10KVolume34.490Open34.710Pre Close31.56MTurnover0.27%Turnover RatioLossP/E (Static)385.82MShares170.47052wk High1.20P/B11.86BFloat Cap29.25052wk Low--Dividend TTM348.52MShs Float497.490Historical High--Div YieldTTM2.73%Amplitude11.540Historical Low34.037Avg Price1Lot Size
About Moderna Company
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Company Profile
SymbolMRNA
Company NameModerna
Listing DateDec 7, 2018
Issue Price23.00
Founded2010
CEOMr. Stephane Bancel
MarketNASDAQ
Employees5800
Fiscal Year Ends12-31
Address325 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-714-6500
Websitehttp://www.modernatx.com
Company Executives
- Name
- Position
- Salary
- Stephane Bancel
- Director and Chief Executive Officer
- 19.88M
- Dr. Jerh Collins, PhD
- Chief Technical Operations and Quality Officer
- --
- Dr. Jacqueline Miller, M.D.
- Chief Medical Officer
- --
- Kate Cronin
- Chief Brand Officer
- --
- James M Mock
- Chief Financial Officer and Principal Accounting Officer
- 17.21M
- Shannon Thyme Klinger
- Chief Legal Officer and Corporate Secretary
- 17.37M
- Tracey Franklin
- Chief People and Digital Technology Officer
- --
- Dr. Rose Loughlin, PhD
- Executive Vice President, Research
- --
- Dr. Stephen Hoge, M.D.
- President
- 9.18M
- Dr. Noubar B. Afeyan, PhD
- Chairman of the Board
- 644.37K
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 578.38K
- Dr. Francois Nader, M.D.
- Independent Director
- 578.40K
- Elizabeth E. Tallett
- Independent Director
- 578.40K
- Dr. Elizabeth G. Nabel, M.D.
- Independent Director
- 578.38K
- Paul Sagan
- Independent Director
- 558.40K
- David M. Rubenstein
- Independent Director
- 551.61K
- Abbas Hussain
- Independent Director
- 609.07K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
